Digest Network Come funziona
Network
/
Società
Su
Non verificato

Summit Therapeutics

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

35 comunicati stampa

Guarda tutti i comunicati
23/07/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Sanità
Farmaceutica
Salute
Oncologia
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026
Fonte
Summit Therapeutics
Emittente
Business Wire
1.00
0
22/07/2026
Mercato del lavoro
Scienza
Igiene alimentare
Medicina - Varie
Sanità
Biotecnologia
Farmaceutica
Salute
Oncologia
Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
Fonte
Summit Therapeutics
Emittente
Business Wire
1.00
0
22/07/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Sanità
Ivonescimab Plus Chemotherapy Shows Consistent, Favorable Overall Survival Results in Western and Asian Patients in Updated Analysis from Global Phase III HARMONi Study
Fonte
Summit Therapeutics
Emittente
Business Wire
1.00
0
16/07/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Oncologia
Summit Therapeutics to Host Second Quarter 2026 Financial Results & Operational Progress Call on July 23, 2026
Fonte
Summit Therapeutics
Emittente
Business Wire
1.00
0
14/07/2026
Oncologia
Salute
Tecnica
Sanità
Farmaceutica
Biotecnologia
Mercato del lavoro
Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.
Fonte
Summit Therapeutics
Emittente
Business Wire
1.00
0
09/06/2026
Finanza
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Oncologia
Summit Therapeutics Announces Proposed Public Offering of Common Stock
Fonte
Summit Therapeutics
Emittente
Business Wire
1.00
0
04/06/2026
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Oncologia
Eventi
Web e Social Network
Summit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conference
Fonte
Summit Therapeutics
Emittente
Business Wire
1.00
0
31/05/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Eventi
Industria
Mercato del lavoro
Web e Social Network
Telefonia e Varie
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China
Fonte
Summit Therapeutics
Emittente
Business Wire
1.00
0
30/05/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Eventi
Industria
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
Fonte
Summit Therapeutics
Emittente
Business Wire
1.00
0
30/04/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2026
Fonte
Summit Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0